Swiss National Bank Raises Stake in Tilray Inc (NASDAQ:TLRY)

Swiss National Bank grew its stake in shares of Tilray Inc (NASDAQ:TLRY) by 0.9% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 938,838 shares of the company’s stock after purchasing an additional 8,400 shares during the period. Swiss National Bank owned approximately 0.20% of Tilray worth $10,599,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. 1832 Asset Management L.P. purchased a new stake in shares of Tilray during the 2nd quarter worth $29,000. Banque Cantonale Vaudoise boosted its position in shares of Tilray by 157.6% during the 3rd quarter. Banque Cantonale Vaudoise now owns 2,602 shares of the company’s stock worth $29,000 after purchasing an additional 1,592 shares in the last quarter. US Bancorp DE boosted its position in shares of Tilray by 247.9% during the 2nd quarter. US Bancorp DE now owns 2,251 shares of the company’s stock worth $41,000 after purchasing an additional 1,604 shares in the last quarter. Covington Capital Management purchased a new stake in shares of Tilray during the 2nd quarter worth $45,000. Finally, BDO Wealth Advisors LLC boosted its position in shares of Tilray by 802.1% during the 2nd quarter. BDO Wealth Advisors LLC now owns 3,383 shares of the company’s stock worth $61,000 after purchasing an additional 3,008 shares in the last quarter. Institutional investors own 12.09% of the company’s stock.

NASDAQ:TLRY opened at $6.86 on Friday. The firm has a market cap of $3.16 billion, a price-to-earnings ratio of -3.59 and a beta of 2.39. The company has a current ratio of 2.25, a quick ratio of 1.13 and a debt-to-equity ratio of 0.16. The company’s 50-day moving average is $9.07 and its two-hundred day moving average is $11.64. Tilray Inc has a 12-month low of $6.29 and a 12-month high of $67.00.

Tilray (NASDAQ:TLRY) last posted its quarterly earnings data on Monday, January 10th. The company reported $0.03 EPS for the quarter, beating the Zacks’ consensus estimate of ($0.09) by $0.12. Tilray had a negative net margin of 66.64% and a negative return on equity of 2.57%. The company had revenue of $155.10 million during the quarter, compared to the consensus estimate of $171.57 million. The business’s quarterly revenue was up 19.8% on a year-over-year basis. On average, equities research analysts forecast that Tilray Inc will post -0.24 earnings per share for the current fiscal year.

Several equities research analysts have commented on the stock. Alliance Global Partners decreased their target price on shares of Tilray from $12.00 to $7.00 in a research report on Friday, January 7th. Stifel Nicolaus decreased their price objective on shares of Tilray from $11.50 to $10.00 and set a “hold” rating on the stock in a research report on Friday, October 8th. Cantor Fitzgerald decreased their price objective on shares of Tilray from $11.80 to $7.40 and set a “neutral” rating on the stock in a research report on Friday, January 7th. Zacks Investment Research upgraded shares of Tilray from a “sell” rating to a “hold” rating in a research report on Wednesday, December 22nd. Finally, MKM Partners decreased their price objective on shares of Tilray from $10.00 to $8.00 and set a “neutral” rating on the stock in a research report on Tuesday. One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $13.62.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.

Featured Article: What is a Derivative?

Institutional Ownership by Quarter for Tilray (NASDAQ:TLRY)

Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.